VF
BOLT icon

Virtu Financial’s Bolt Biotherapeutics BOLT Stock Holding History

Virtu Financial’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,478
Closed -$16K – 1395
2024
Q4 		$16K Buy
+1,478
New +$17.9K ﹤0.01% 1330
2024
Q2 		– Sell
-547
Closed -$15K – 1341
2024
Q1 		$15K Buy
+547
New +$12.7K ﹤0.01% 1205
2021
Q4 		– Sell
-729
Closed -$184K – 1731
2021
Q3 		$184K Buy
+729
New +$206K 0.02% 946

Other funds holding BOLT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial's BOLT Position: Q1 2025 in Review

Virtu Financial sold out of Bolt Biotherapeutics (BOLT) in Q1 2025, closing a stake of 1,478 shares — an estimated $16K sold.

Virtu Financial first reported a position in BOLT in Q3 2021 and held it in 3 quarters. The position peaked at $184K in Q3 2021. 29 funds tracked by Wall St. Rank hold BOLT as of Q1 2025.

  • Virtu Financial reported no remaining Bolt Biotherapeutics position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 1,478 Bolt Biotherapeutics shares in Q1 2025, an estimated $16K.
  • Virtu Financial first reported a position in Bolt Biotherapeutics in Q3 2021 and held it in 3 quarters.
  • Virtu Financial's Bolt Biotherapeutics position peaked at $184K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.